How much would it cost me to buy a day’s abstinence? Behaviour therapies in the addictions John Marsden, Ph.D. Division of Psychological Medicine & Psychiatry.

Slides:



Advertisements
Similar presentations
13 Principles of Effective Addictions Treatment
Advertisements

Alcohol screening and brief intervention delivery to an Irish cohort of opiate dependent methadone maintained patients. Catherine Darker (PhD) Department.
Luke Mitcheson Clinical Psychologist
Translational Research on Reinforcement as a Determinant of Substance Use Disorders Stephen T. Higgins, Ph.D. University of Vermont.
Karran A. Phillips, MD, MSc NIDA Intramural Research Program AMERSA Annual Meeting November 8, 2014.
Addiction UNIT 4: PSYA4 Content The Psychology of Addictive Behaviour Models of Addictive Behaviour  Biological, cognitive and.
Contingency Management Motivational Incentives: Past, Present and Future Maxine Stitzer, Ph.D. Johns Hopkins University SOM NIDA/CTN Regional Dissemination.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence September–October 2008.
Substance-Use Disorders Lori Ridgeway PSYC What is abuse? Criteria Failure to meet responsibilities Use despite potential dangers Legal problems.
MSc in Addiction Studies Learning Theories of Addiction Operant conditioning, social learning theory and contingency management.
Challenges and Successes Treating Adolescent Substance Use Disorders Janet L. Brody, Ph.D. Center for Family and Adolescent Research (CFAR), Oregon Research.
Evaluating Cocaine Use Outcome Measures: Relationships with Long Term Cocaine Use and Functioning Brian D. Kiluk, Ph.D. Kathleen M. Carroll, Ph.D. Yale.
Treatment of Methamphetamine Dependence: Does Treatment Work? Mary Lynn Brecht, Ph.D. Richard A. Rawson, Ph.D Semel Institute for Neuroscience and Human.
TREATING SPECIAL POPULATIONS. OVERVIEW Tobacco Treatment Smoking Outcomes Co-occurring Disorders Integration Tobacco Prevention.
A Health Based Approach Within The UN Conventions: Examples Of Practice Fay Watson, Vice Chair: EU Civil Society Forum on Drugs.
Evidence for twelve step facilitation in the medical literature Jonathan Chick HLO’s meeting, York, March 2014.
Addressing Crystal Methamphetamine Use Among Gay and Bisexual Men: A Treatment Center’s Response Joe Ruggiero, Ph.D. –Director, Outpatient Services The.
MIEDAR, PAMI and BEYOND Maxine Stitzer, Ph.D. Johns Hopkins SOM APHA Symposium Denver, CO November 10, 2010.
Continuing Care for Adolescents with Substance Use Disorders: Opportunities for Health Services Research Thomas M. Brady, Ph.D. Division of Epidemiology,
Application of Behavioral Economics to Behavior Change Azaher Molla H 571: Theory of Heath Behavior 1.
Low-Cost Contingency Management in Community Settings
Practical Application of Contingency Management Michael J. McCann, MA Matrix Institute on Addictions.
SUBSTANCE USE DISORDERS GENERAL METHODS OF TREATMENT Inpatient Detoxification and Rehabilitation Outpatient Individual, Couple, or Family Counseling Self-help.
Psychological interventions in addictive disorders MRCPsych addiction psychiatry seminar March 2010.
NIDA Grants: U10DA015831, K24DA022288, U10DA020024, K23DA022297, U10DA Predictors of Outcome in the Multi-Site CTN Prescription Opioid Addiction.
Evidence-Based Practice: Psychosocial Interventions Maxine Stitzer, Ph.D. Johns Hopkins Univ SOM NIDA Blending Conference June 3, 2008 Cincinnati, Ohio.
Contingency Management in Problem Gambling Treatment Jeremiah Weinstock, Ph.D. University of Connecticut Health Center Farmington, CT USA.
Principles of Drug Addiction Treatment (Section 5 continued…) UCLA Integrated Substance Abuse Programs Continuum of Care 1.
Jaime Delgadillo, PhD Leeds Community Healthcare NHS Trust and University of York Feasibility RCT of brief interventions for depression and co-occurring.
Michael Prendergast UCLA Integrated Substance Abuse Programs Deborah Podus UCLA Integrated Substance Abuse Programs John Finney Veterans Affairs Palo Alto.
Chapter 3 Addictions: Theory and Treatment. Drug Addiction Behavioral pattern of drug use Overwhelming involvement Securing of its supply Tendency to.
Effect of Depression on Smoking Cessation Outcomes Sonne SC 1, Nunes EV 2, Jiang H 2, Gan W 2, Tyson C 1, Reid MS 3 1 Medical University of South Carolina,
Contingency management: Using principles of reinforcement to improve drug abuse treatment Nancy Petry, Ph.D. University of Connecticut Health Center Farmington,
Increasing Attendance and Compliance With Incentives Maxine Stitzer, Ph.D. Johns Hopkins Univ SOM Improving Care Conference Johns Hopkins Center for Behavior.
Specific Aims  Modify a previously used ACASI (audio computer assisted structured interview) assessment tool, the Sexual Behavior Inventory (SBI), for.
Improving Outcomes in Methadone Treatment Cognitive/Behavioral Treatment Contingency Management Michael J. McCann, MA Matrix Institute on Addictions Sptember.
Meta-Analysis of HIV Risk Reduction Interventions Within Drug Abuse Treatment Programs By: Dana Trent June 2001
EMPIRICALLY-SUPPORTED TREATMENTS FOR STIMULANT DEPENDENCE RICHARD A. RAWSON, Ph.D. UCLA INTEGRATED SUBSTANCE ABUSE PROGRAMS (ISAP) October 9, 2004.
Contingency Management Contingency management (CM) refers to the systematic application of basic principles delineated by workers in the field of the Experimental.
Are Incentives Effective in Improving Participation and Outcomes in Treatment for Substance-Abusing Offenders? Michael L. Prendergast, Ph.D. Elizabeth.
MOTIVATIONAL INCENTIVES IN THE CTN: RESULTS, CLINICAL IMPLICATIONS, AND DISSEMINATION CHRISTINE HIGGINS, DISSEMINATION SPECIALIST, CTN-MID-ATLANTIC NODE.
Motivational Incentives: Utility in Health Care Settings Maxine Stitzer, Ph.D. Johns Hopkins Univ SOM Christiana Care Health Systems Conference Addressing.
PAMI Promoting Awareness of Motivational Incentives: Focus on Founding Principles and an Implementation Checklist Donald A Calsyn, Ph.D. Pacific Northwest.
Reducing adolescent cannabis abuse and co-occurring problems through family-based intervention Howard Liddle, Ed.D., Cynthia Rowe, Ph.D., Gayle Dakof,
Abstinence Incentives for Methadone Maintained Stimulant Users: Outcomes for Those Testing Stimulant Positive vs Negative at Study Intake Maxine L. Stitzer.
The COMBINE Study: Design and Methodology Stephanie S. O’Malley, Ph.D. for The COMBINE Study Research Group JAMA Vol. 295, , 2006 (May 3 rd.
Treatment for Substance Abusers in the Therapeutic Community.
1 Improving SUD Continuity of Care: Bringing Science to Practice Steven J. Lash, Ph.D. Associate Professor of Psychiatry and Neurobehavioral Science, Salem.
Abstinence Incentive Effects in Psychosocial Counseling Patients Testing Stimulant Positive vs Negative at Treatment Entry Maxine L. Stitzer Johns Hopkins.
Table 1. Prediction model for maximum daily dose of buprenorphine-naloxone in a 12-week treatment condition Baseline Predictors Maximum Daily Dose Standardized.
California Addiction Training and Education Series Jeanne L. Obert, MFT, MSM Executive Director, Matrix Institute on Addictions Methamphetamine Behavioral.
Relational Discord at Conclusion of Treatment Predicts Future Substance Use for Partnered Patients Wayne H. Denton, MD, PhD; Paul A. Nakonezny, PhD; Bryon.
BUMI-CBT กับการช่วยเหลือผู้ป่วย ให้เปลี่ยนแปลง พฤติกรรมดื่ม แอลกอฮอล์ ดรุณี ภู่ขาว (Bsc. Nursing, MS (Mental heath), MN, PhD Candidate, Department of Psychiatry,
TREATMENT OF SUBSTANCE USE DISORDERS TX myths 1. Nothing works 2. One approach is superior to all others (“one true light” tradition) 3. All treatment.
Combined Pharmacological and Behavioral Therapy and HIV Risk Reduction Jennifer Schroeder, David Epstein, Katherine Belendiuk, Jessica Willner-Reid, John.
Baseline Characteristics by Primary Substance of Abuse of Outpatient Clients in a Web-based Intervention Trial Aimee N. C. Campbell, Ph.D. 1,2,3, Edward.
Ten Years of Pharmacotherapy Trials in the CTN: An Overview.
Treatments for Methamphetamine-Related Disorders Richard A. Rawson, Ph.D. UCLA Integrated Substance Abuse Program, Vancouver, Canada Nov, 16,
Management of Substance Use Disorder Module P: Addiction-Focused Pharmacotherapy.
Practical Application of Contingency Management Michael J. McCann, MA Matrix Institute on Addictions.
What the National Institute on Drug Abuse’s Clinical Trials Network Can Do for You? Major Findings from Medication Trials and Implications for Community-Based.
Randomized Controlled CTN Trial of OROS-MPH + CBT in Adolescents with ADHD and Substance Use Disorders Paula Riggs, M.D., Theresa Winhusen, PhD., Jeff.
Brief Intervention. Brief Intervention has a number of different definitions but usually encompasses: –assessment –provision of education, support and.
Methadone maintenance in Michigan: Five years of data using a contingency management approach Gary Rhodes, M.A., L.L.P. Golfo Tzilos, M.A. Mark Greenwald,
Date of download: 6/27/2016 Copyright © 2016 American Medical Association. All rights reserved. From: A Comparison of Contingency Management and Cognitive-Behavioral.
Foundations of Addictions Counseling, 3/E David Capuzzi & Mark D. Stauffer Copyright © 2016, 2012, 2008 by Pearson Education, Inc. All Rights Reserved.
1 Drongen, 3 februari 2016 Community Reinforcement Approach (CRA) + Contingency Management (CM) Ruth Verbeken.
Section 27: Cognitive Behavioral Therapy I
Efforts to Reduce Meth Use and Sexual Risk
Regional Dissemination Conference
Presentation transcript:

How much would it cost me to buy a day’s abstinence? Behaviour therapies in the addictions John Marsden, Ph.D. Division of Psychological Medicine & Psychiatry National Addiction Centre, King’s College London, UK

“Failure” Rates for Addictions (reduction <50% in use after 6 mos.) O’Brien & McLellan, 1996, The Lancet

Comparative Rates for Treatment Compliance & Relapse O’Brien & McLellan, 1996, The Lancet

Behavioural interventions ► Theoretical foundations ► Laboratory and clinical foundations ► Reinforcement …. a process wherein a stimulus event increases the future probability of drug use by acting as a consequence. …. a process wherein a stimulus event increases the future probability of drug use by acting as a consequence. ► Effective interventions ► Combination therapies ► Key issues and future directions

Theoretical foundations

B.F. Skinner ► Three-term contingency Discriminative stimulusDiscriminative stimulus Operant responseOperant response Reinforcement (positive and negative)Reinforcement (positive and negative) ► Behaviour modified by consequences ► Schedules of reinforcement ► Drug self-adminstration at the core ► Drugs function as primary reinforcers ► Altering behavioural contingencies

Laboratory Foundations (1) ► Opiates, psychostimulants, nicotine, alcohol and cannabis serve as reinforcers in a diverse range of species ► Behaviours aimed at obtaining drugs exhibit strong motivational pressure ► Animal drug use can be modified by manipulating variables that affect other operant behaviours: Increasing number of responses requiredIncreasing number of responses required By blocking/eliminating the reinforcementBy blocking/eliminating the reinforcement By punishing the responses on which drug reinforcement is contingentBy punishing the responses on which drug reinforcement is contingent

Laboratory Foundations (2) ► Associative learning and memory processes underpin addiction

Treatment Protocol ► Weeks x weekly counseling2x weekly counseling 3x weekly urine testing3x weekly urine testing ► Weeks x weekly counseling1x weekly counseling 2x weekly urine testing2x weekly urine testing ► Months 7-12 Aftercare – 1x monthly check-in with counsellorAftercare – 1x monthly check-in with counsellor Random urine testingRandom urine testingElements:  Antabuse therapy (clinical punishment)  Relationship counseling & skills training  Occupational assistance  Vouchers for goods and services

Vouchers (weeks 1-12 only) ► Urine tests negative for benzoylecgoine (BE) earned points worth $0.25. ► The first BE negative earns 10 $0.25 ► Voucher for each subsequent consecutive negative test increases by 5 pts. ► The equivalent of $10 bonus is earned for every 3 consecutive negative tests.

Voucher protocol ► BE-positive tests or failure to give a specimen ‘reset’ vouchers back to initial value. ► BE-positive tests or failure to give a specimen reset vouchers back to initial value. ► 5 consecutive negative tests returned vouchers back to the value preceding a reset. ► Vouchers were exchangeable for retail items in community; max. earnings possible = $ ► All purchases were made by staff and had to be deemed by therapists to be recovery appropriate.

Higgins et al. (1994) Incentives Improve Outcome in Outpatient Behavioral Treatment of Cocaine Dependence. Arch. Gen. Psychiat, 51, ► 40 patients randomlized to two groups ► Treatment lasts for 25 weeks. ► 2x weekly counseling and 3x weekly urinalysis in weeks 1-12; reduced to 1x weekly counseling and 2x weekly urinalysis in weeks ► Counseling in both groups based on the Community Reinforcement Approach (CRA). ► Voucher group rewarded for BE-negative results in weeks During weeks 13-24, both groups received only a single $1 lottery ticket for each BE-negative test.

Higgins et al. (2000) Contingent Reinforcement Increases Cocaine Abstinence During Outpatient Treatment and 1 Year of Follow-up. JCCP, 2000, 68, ► 70 patients randomized to two groups. ► Treatment over 24 weeks and 1 year follow-up ► All get CRA + vouchers ► One group receives vouchers contingent on cocaine abstinence ► Other group receives vouchers non-contingently (yoked control) ► 24 weeks treatment and 1 year of follow-up

Iguchi et al. (1997) Reinforcing operants other than abstinence in drug abuse treatment. JCCP, 65, 425- ► 103 MMT patients who completed 6 weeks of baseline testing to one of three conditions: (a) standard MMT (b) MMT + up to $15/week in vouchers for submitting drug-free urine samples (b) MMT + up to $15/week in vouchers for submitting drug-free urine samples (c) MMT + up to $15/week in vouchers for submitting treatment plan tasks ► Interventions over 12 weeks ► Follow-up over 6 months

TP Intervention has greater time effect that other 2 treatmernts % drug-free urine samples

Epstein et al. (2003) Cognitive–Behavioral Therapy Plus Contingency Management for Cocaine Use: Findings During Treatment and Across 12-Month Follow-Up. Psychol Addict Behav; 17, 73–82. ► 193 MMT outpatients randomized tovoucher availability (contingent or not contingent on cocaine-negative urine testing. ► Follow-ups at 3, 6 and 12 months

Patients abstinent from cocaine over 87 test days

A meta-analysis of voucher- based reinforcement therapy for substance use disorders. Jennifer Lussier et al. (2006) Addiction, 101,

Methods ► Effect sizes calculated for controlled studies VBRT published between 1/91 & 3/04 ► 65 studies reviewed, including 40 where effects of contingent vouchers were experimentally isolated ► Focus was on period when vouchers were available ► Studies grouped by moderator variables: type of drug targeted, control, duration of VBRT, voucher $ value, voucher delivery immediate or delayed, study setting

Experimental vs control conditions ► Results as pearson correlation coefficient where as a guide: r = 0.10 (difference in effectiveness of 55% vs. 45%) r = 0.30 (65% vs. 35%) r = 0.30 (65% vs. 35%) r = 0.50 ( 75% vs. 25%) ► 65 studies reviewed, including 40 where effects of contingent vouchers were experimentally isolated ► Studies grouped by moderator variables: type of drug targeted, control, duration of VBRT, voucher $ value, voucher delivery immediate or delayed, study setting

Effects for different substances Substance N studies Mean weighted ES cocaine opiates30.39 cocaine & opiates polydrug60.20 cannabis10.57 alcohol10.32 nicotine20.48

2x2 factorial design Group 1 Placebo medication & control VBRT Group 2 Active medication & control VBRT Group 3 Placebo medication & active VBRT Group 4 Active medication & active VBRT

Lambeth Harbour Study ► Randomised controlled trial ► Voucher-CM only ► Synergistic voucher-CM + group based CBT ► 82 service users (primary cocaine) ► 8 week intervention ► 3 x weekly on-site, urine testing for cocaine ► 8 x 1.25 hr CBT with CM discussion focus ► All participants receive 8 x 1 hr keworking ► Follow-ups:  At 1-month (week 12)  At 3-months (week 24)

Outcome criteria ► (1) Immediate abstinence during weeks 7 & 8. Participants must provide at least 2 cocaine negative urine tests in each of weeks 7 and 8 and no positive tests. ► (2) Short-term abstinence no reported use of cocaine during weeks 9-12 and provision of a negative urine test at the 12- week (1-month) follow-up; and ► (3) Longer-term abstinence no reported use of cocaine during weeks and provision of a negative urine test at the 3- month follow-up. Statistical analysis by relative risk ratios for outcome criteria and NNT

Lambeth voucher-CM ► 24 tests on Monday, Wednesday & Friday ► Escalating schedule starting at £1 ► Up by £0.5 for each successive –ive test ► Bonus for each series of 6 –ive tests ► Re-set following +ive test or DNA ► Return to previous level for 6 –ives (if time) ► Voucher for attending drop-in for 1.25 hours ► Final bonus for attending for all 24 tests ► Total voucher value possible = £323 ► Harbour voucher credits exchanged for store gift certificates as Argos, Footlocker, Woolworths etc.

The Harbour Steps Week 1Week 2Week 3Week 4Week 5Week 6Week 7Week 8

Lambeth CBT ► All CBT attenders receive CM ► CBT has joint CM coaching and CBT skills training purpose ► Key themes:  Showing you the ropes  The CM rules!  Clearance reassurance  Personal voucher goals  Getting rolling  Brushing off a set-back  The crunch zone  Helping others  CBT skills

Key issues and future directions ► Behavioural interventions using CM are effective at encouraging initial abstinence. ► When contingencies removed effects taper off. ► However, they are rarely used in routine treatment delivery settings and outside the USA. ► They may be particularly effective when combined/integrated with other interventions. ► Further development of reinforcement schedules is needed: non-abstinent reinforcement as initial step?